Two nerve blocks go Head-to-Head for mastectomy pain relief
NCT ID NCT06548646
First seen Oct 16, 2026 ยท Last updated Oct 16, 2026
Summary
Researchers compare two ultrasound-guided nerve blocks, the thoracic interfascial plane block and the erector spinae plane block, to see which controls pain better after modified radical mastectomy for breast cancer. The study enrolls 200 women aged 21 and older who are scheduled for this surgery. Participants receive one of the two blocks before surgery, and researchers track pain scores, pain medication use, side effects, recovery milestones, and long-term outcomes like persistent pain and quality of life over six months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Two ultrasound-guided nerve blocks: the thoracic interfascial plane block and the erector spinae plane block
- What this could lead to
- If one block proves better, it could become a standard option for managing pain after breast cancer surgery, possibly reducing reliance on opioids.
- What could go wrong
- This is a single-center study of 200 women, so results may not apply broadly. Nerve blocks can fail or cause temporary numbness, and long-term pain relief is not guaranteed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
200 people
The number who actually took part.
- Started
-
Nov 2024
- Finished
-
Jun 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Female patients older than 21 years old * American Society of Anesthesiologists (ASA) physical status II. Exclusion Criteria: * Known allergy to one of the study medications. * Skin infections at the site of the needle puncture. * Significant organ dysfunction (hepatic, renal, or cardiac dysfunction), coagulopathy or recent anticoagulant use, epilepsy. * Patients diagnosed with obstructive sleep apnoea, pulmonary compromise .
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ainshams University Hospitals
Cairo, Abbasiya, 1181, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A handheld probe could flag breast tumors without a needle
- Does chemo brain fuel lasting pain? researchers track 182 women to find out
- Can adding anlotinib to chemotherapy slow HER2-Negative breast cancer?
- Can breast cancer surgery be done without general anesthesia? researchers test nerve blocks plus hypnosis
- Can a single breast MRI at 45 catch cancer earlier?
- Can a dye and tracer map lymph nodes in the most aggressive breast cancer?